385 related articles for article (PubMed ID: 6976371)
1. Production of monoclonal antibodies against MM antigen: the serologic identification of MM antigen with Ly-6.2 alloantigen.
Seto M; Takahashi T; Tanimoto M; Nishizuka Y
J Immunol; 1982 Jan; 128(1):201-5. PubMed ID: 6976371
[TBL] [Abstract][Full Text] [Related]
2. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes.
Seto M; Takahashi T; Nakamura S; Matsudaira Y; Nishizuka Y
Cancer Res; 1983 Oct; 43(10):4768-73. PubMed ID: 6192909
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies directed to different tumor-associated antigens on a murine mammary tumor cell line, MM46.
Oshima H; Nishiya S
Jpn J Exp Med; 1987 Aug; 57(4):207-15. PubMed ID: 2448508
[TBL] [Abstract][Full Text] [Related]
4. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
5. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
Flood PM
J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
[TBL] [Abstract][Full Text] [Related]
6. Xenogeneic monoclonal antibody to an Ly-6-linked murine cell surface antigen: differential reactivity with T cell subpopulations and bone marrow cells.
Dumont FJ; Coker LZ; Habbersett RC; Treffinger JA
J Immunol; 1985 Apr; 134(4):2357-65. PubMed ID: 3156181
[TBL] [Abstract][Full Text] [Related]
7. [Preparation and anti-tumor activity of monoclonal antibody against ascitic mammary tumor MM46 cells].
Takahashi T; Seto M; Hara T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):544-50. PubMed ID: 6192760
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody that recognizes an Ly-6-linked antigen inhibits the generation of functionally active T cell subsets.
Flood PM; Murphy DB; Horowitz M; LeClair KP; Smith FR; Stockert E; Palladino MA; DeLeo AB
J Immunol; 1985 Jul; 135(1):63-72. PubMed ID: 2987354
[TBL] [Abstract][Full Text] [Related]
9. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
Takahashi T; Seto M; Hara T
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of tissue distribution of Ly10-like murine alloantigen(s) with antisera and monoclonal antibodies.
Kuśnierczyk P; Wysocka M; Szkudlarek J; Steuden I; Szymaniec S; Kisielow P
Arch Immunol Ther Exp (Warsz); 1986; 34(4):409-19. PubMed ID: 3800600
[TBL] [Abstract][Full Text] [Related]
11. BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice.
McNagny KM; Cazenave PA; Cooper MD
J Immunol; 1988 Oct; 141(8):2551-6. PubMed ID: 3262662
[TBL] [Abstract][Full Text] [Related]
12. Lym 7.2: monoclonal antibody defining an alloantigen similar or identical to Ly 7.2.
Lanier LL; Warner NL
Hybridoma; 1982; 1(3):227-41. PubMed ID: 6208126
[TBL] [Abstract][Full Text] [Related]
13. Blocking of cytotoxic T-cell function of MOLF/Ei mice by anti-Ly 35.1 monoclonal antibody.
Mieno M; Udono H; Ikegami S; Tada N; Shiku H; Nakayama E
Immunology; 1989 Nov; 68(3):431-3. PubMed ID: 2592017
[TBL] [Abstract][Full Text] [Related]
14. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
[TBL] [Abstract][Full Text] [Related]
15. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
16. Ly-15: a new murine lymphocyte alloantigenic locus.
Potter TA; Hogarth PM; McKenzie IF
Transplantation; 1981 May; 31(5):339-42. PubMed ID: 6785912
[TBL] [Abstract][Full Text] [Related]
17. Ly 9, an alloantigenic marker of lymphocyte differentiation.
Mathieson BJ; Sharrow SO; Bottomly K; Fowlkes BJ
J Immunol; 1980 Nov; 125(5):2127-36. PubMed ID: 7000897
[TBL] [Abstract][Full Text] [Related]
18. H-41, a new minor histocompatibility locus. I. Histogenetic analysis.
Juretić A; Vucak I; Malenica B; Nagy ZA; Klein J
J Immunol; 1984 Dec; 133(6):2950-4. PubMed ID: 6386980
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
20. Characterization of T lymphocyte subsets with monoclonal antibodies: discovery of a distinct marker, Ly-m22, of T suppressor cells.
Chan MM; Tada N; Kimura S; Hoffmann MK; Miller RA; Stutman O; Hämmerling U
J Immunol; 1983 May; 130(5):2075-8. PubMed ID: 6187835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
